249 related articles for article (PubMed ID: 25311082)
21. Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma.
Peng X; Yu S; Kou Y; Dang J; Wu P; Yao Y; Shen J; Liu Y; Wang X; Cheng Z
Ann Hematol; 2023 Nov; 102(11):3115-3124. PubMed ID: 37400729
[TBL] [Abstract][Full Text] [Related]
22. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of whole-body dynamic
Yin J; Wang H; Zhu G; Chen N; Khan MI; Zhao Y
Heliyon; 2023 Sep; 9(9):e19749. PubMed ID: 37809527
[TBL] [Abstract][Full Text] [Related]
24. Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma.
Goksel S; Ilkkilic K; Bulbul O; Akdogan E
Nucl Med Commun; 2022 Oct; 43(10):1077-1083. PubMed ID: 36006402
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of
Mohamed E; Needham A; Psarelli E; Carroll M; Vinjamuri S; Sanghera B; Wong WL; Halloran C; Ghaneh P
Eur J Surg Oncol; 2020 Aug; 46(8):1532-1538. PubMed ID: 32070641
[TBL] [Abstract][Full Text] [Related]
26. [The Value of Baseline PET/CT Imaging of Bone Marrow
Wang Y; Zhao M; Yuan L; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):439-444. PubMed ID: 38660849
[TBL] [Abstract][Full Text] [Related]
27. Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma.
Jelicic J; Juul-Jensen K; Bukumiric Z; Runason Simonsen M; Roost Clausen M; Ludvigsen Al-Mashhadi A; Schou Pedersen R; Bjørn Poulsen C; Ortved Gang A; Brown P; El-Galaly TC; Larsen TS
Cancer Med; 2024 Jun; 13(12):e7239. PubMed ID: 38888359
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Lin J; Xie G; Liao G; Wang B; Yan M; Li H; Yuan Y
Oncotarget; 2017 May; 8(20):33884-33896. PubMed ID: 27980228
[TBL] [Abstract][Full Text] [Related]
29. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of
Wang J; Yu X; Shi A; Xie L; Huang L; Su Y; Zha J; Liu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14535-14547. PubMed ID: 37567986
[TBL] [Abstract][Full Text] [Related]
31. Metabolic Tumor Volume by
Matsumoto Y; Baba S; Endo M; Setsu N; Iida K; Fukushi JI; Kawaguchi K; Okada S; Bekki H; Isoda T; Kitamura Y; Honda H; Nakashima Y
Biomed Res Int; 2017; 2017():8132676. PubMed ID: 28852650
[TBL] [Abstract][Full Text] [Related]
32. Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice.
Terao T; Machida Y; Tsushima T; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
Br J Haematol; 2020 Oct; 191(2):223-230. PubMed ID: 32253760
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Impact of Metabolic Heterogeneity in Patients With Newly Diagnosed Multiple Myeloma Using 18F-FDG PET/CT.
Terao T; Machida Y; Hirata K; Kuzume A; Tabata R; Tsushima T; Miura D; Narita K; Takeuchi M; Tateishi U; Matsue K
Clin Nucl Med; 2021 Oct; 46(10):790-796. PubMed ID: 34172600
[TBL] [Abstract][Full Text] [Related]
34. Optimal index for detecting splenic involvement on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diffuse large B-cell lymphoma.
Kozuki R; Sugimoto T; Goto H; Miyamoto N; Hirakawa Y; Umeno A; Idei M; Tagawa S; Namba F; Tani R; Ohmori M; Hamanaka A; Adachi S; Tomita M
Medicine (Baltimore); 2024 Mar; 103(9):e37290. PubMed ID: 38428864
[TBL] [Abstract][Full Text] [Related]
35. Conventional and novel [
Leithner D; Flynn JR; Devlin SM; Mauguen A; Fei T; Zeng S; Zheng J; Imber BS; Hubbeling H; Mayerhoefer ME; Bedmutha A; Luttwak E; Corona M; Dahi PB; Luna de Abia A; Landego I; Lin RJ; Palomba ML; Scordo M; Park JH; Tomas AA; Salles G; Lafontaine D; Michaud L; Shah GL; Perales MA; Shouval R; Schöder H
J Hematol Oncol; 2024 Apr; 17(1):21. PubMed ID: 38649972
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Sesques P; Tordo J; Ferrant E; Safar V; Wallet F; Dhomps A; Brisou G; Bouafia F; Karlin L; Ghergus D; Golfier C; Lequeu H; Lazareth A; Vercasson M; Hospital-Gustem C; Schwiertz V; Choquet M; Sujobert P; Novelli S; Mialou V; Hequet O; Carras S; Fouillet L; Lebras L; Guillermin Y; Leyronnas C; Cavalieri D; Janier M; Ghesquières H; Salles G; Bachy E
Clin Nucl Med; 2021 Aug; 46(8):627-634. PubMed ID: 34115706
[TBL] [Abstract][Full Text] [Related]
38. The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma.
Klabatsa A; Chicklore S; Barrington SF; Goh V; Lang-Lazdunski L; Cook GJ
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):276-82. PubMed ID: 24057459
[TBL] [Abstract][Full Text] [Related]
39. Correlation of 18-fluorodeoxyglucose PET/computed tomography parameters and clinical features to predict outcome for diffuse large B-cell lymphoma.
Baratto L; Wu F; Minamimoto R; Hatami N; Liang T; Sabile J; Advani RH; Mittra E
Nucl Med Commun; 2021 Jul; 42(7):792-799. PubMed ID: 33741852
[TBL] [Abstract][Full Text] [Related]
40. PET/MRI in Endometrial Cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival.
Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Zheng QY; Cheng MF; Chen JL; Shih TT
Acad Radiol; 2024 Mar; 31(3):939-950. PubMed ID: 37714718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
